Aliskiren Ali+


Indications and Reactions:

Role Indications Reactions
Primary
Hypertension 66.4%
Diabetes Mellitus 9.3%
Coronary Artery Disease 4.7%
Cardiac Failure 2.6%
Hypercholesterolaemia 2.3%
Chronic Obstructive Pulmonary Disease 1.8%
Atrial Fibrillation 1.6%
Essential Hypertension 1.6%
Hyperuricaemia 1.6%
Type 2 Diabetes Mellitus 1.6%
Hypothyroidism 1.2%
Hyperlipidaemia 1.1%
Depression 0.9%
Myocardial Ischaemia 0.8%
Renal Failure 0.7%
Dehydration 0.4%
Iron Deficiency 0.4%
Angina Pectoris 0.3%
Angiopathy 0.3%
Aortic Valve Replacement 0.3%
Urine Albumin/creatinine Ratio Increased 16.2%
Death 12.1%
Vascular Graft 9.6%
Hypertensive Crisis 9.1%
Hypertension 6.6%
Renal Failure 6.6%
Microalbuminuria 5.1%
Myocardial Infarction 4.5%
Left Ventricular Hypertrophy 3.5%
Renal Failure Chronic 3.5%
Glycosylated Haemoglobin Increased 3.0%
Dyspnoea 2.5%
Nausea 2.5%
Syncope 2.5%
Tachycardia 2.5%
Dizziness 2.0%
Percutaneous Coronary Intervention 2.0%
Renal Failure Acute 2.0%
Urinary Retention 2.0%
Urine Albumin/creatinine Ratio 2.0%
Secondary
Hypertension 62.0%
Diabetes Mellitus 14.0%
Hypercholesterolaemia 4.0%
Type 2 Diabetes Mellitus 3.3%
Depression 2.7%
Coronary Artery Disease 2.0%
Asthma 1.3%
Cerebrovascular Accident 1.3%
Chronic Obstructive Pulmonary Disease 1.3%
Pain 1.3%
Platelet Aggregation Inhibition 1.3%
Diarrhoea 0.7%
Gastric Disorder 0.7%
Heart Rate 0.7%
Hyperlipidaemia 0.7%
Lipids 0.7%
Microalbuminuria 0.7%
Renal Failure 0.7%
Urine Albumin/creatinine Ratio Increased 0.7%
Myocardial Infarction 14.6%
Hypertensive Crisis 10.4%
Left Ventricular Hypertrophy 10.4%
Renal Failure 10.4%
Pulmonary Embolism 8.3%
Renal Mass 6.3%
Stent Placement 6.3%
Hypercholesterolaemia 4.2%
Peripheral Arterial Occlusive Disease 4.2%
Urine Albumin/creatinine Ratio Increased 4.2%
Cerebrovascular Accident 2.1%
Chest Discomfort 2.1%
Glomerular Filtration Rate Decreased 2.1%
Heart Rate Decreased 2.1%
Implantable Defibrillator Insertion 2.1%
Microalbuminuria 2.1%
Nocturia 2.1%
Percutaneous Coronary Intervention 2.1%
Post Procedural Complication 2.1%
Renal Artery Stent Placement 2.1%

Drug Data